BRIEF-First dedicated outcome trials of empagliflozin in chronic heart failure initiated By: Reuters: Company News March 17, 2017 at 08:49 AM EDT * First dedicated outcome trials of Empagliflozin in chronic heart failure initiated Read More >> Related Stocks: Eli Lilly